2016_Head & Neck COURSE BOOK

Key points NPC  ‐

• The current treatment recommendation is  – radiotherapy alone for early stage – concurrent chemoradiotherapy (cisplatin‐based)  for locally advanced stages (III–IVB, bulky IIb) • IMRT is recommended for target coverage and  normal tissue sparing (xerostomia etc) ,  • Beware of the many critical normal tissues at risk! • Loco‐regional control in excess of 90% at 2–4 years  with IMRT and concurrent chemotherapy • 5‐year overall survival of ~70%